Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 2;9(3):271.
doi: 10.3390/foods9030271.

Phytopharmacological Strategies in the Management of Type 2 Diabetes Mellitus

Ana M Duarte  1 , Maria P Guarino  2 , Sónia Barroso  1 , Maria M Gil  1
Affiliations
Review

Phytopharmacological Strategies in the Management of Type 2 Diabetes Mellitus

Ana M Duarte et al. Foods. .

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic disease which corresponds to 90% of the worldwide cases of diabetes, mainly due to epigenetic factors such as unhealthy lifestyles. First line therapeutic approaches are based on lifestyle changes, most of the time complemented with medication mostly associated with several side effects and high costs. As a result, the scientific community is constantly working for the discovery and development of natural therapeutic strategies that provide lower financial impact and minimize side effects. This review focus on these nature-based therapeutic strategies for prevention and control of T2DM, with a special emphasis on natural compounds that present pharmacological activity as dipeptidyl peptidase-4 (DPP4), alpha-amylase, alpha-glucosidase, lipase, and protein tyrosine phosphatase 1B (PTP1B) inhibitors.

Keywords: alpha-amylase; alpha-glucosidase; dipeptidyl peptidase-4 (DPP4); lipase; phytopharmacology; protein tyrosine phosphatase 1B (PTP1B); type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Examples of chemical structures of some of the natural compounds with inhibitory activity against target enzymes in the prevention and control of T2DM. (a) theaflavin-3-gallate; (b) fucofuroeckol A; (c) triterpene oleanolic acid; (d) panclicins A; (e) percyquinnin; (f) mulberrofurans J; (g) isoderrone; (h) 3-bromo-4,5-Bis-(2,3-dibromo-4,5-dihydroxybenzyl) pyrocatechol; (i) resveratrol; (j) flavone; (k) kaempferol diglycoside.
See this image and copyright information in PMC

References

    1. Sharifuddin Y., Chin Y.X., Lim P.E., Phang S.M. Potencial bioactive compounds from seaweed for diabetes management. Mar. Drugs. 2015;13:5447–5491. doi: 10.3390/md13085447. - DOI - PMC - PubMed
    1. Gago A.S. Master’s Thesis. Faculdade de Ciências e Tecnologia; Algarve, Portugal: 2016. Compostos Bioativos de Microalgas com Interesse no Tratamento da Diabetes.
    1. Motshakeri M., Ebrahimi M., Goh Y.M., Othman H.H., Hair-Bejo M., Mohamed S. Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model. Evid. Based Complment. Altern. 2014;2014:1–11. doi: 10.1155/2014/379407. - DOI - PMC - PubMed
    1. Chakraborty C., Hsu M.J., Agoramoorthy G. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with sitagliptin and inhibitor diprotin-A. Cell Biochem. Biophys. 2014;70:907–922. doi: 10.1007/s12013-014-9998-0. - DOI - PubMed
    1. Chatterjee S., Khunti K., Davies M.J. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi: 10.1016/S0140-6736(17)30058-2. - DOI - PubMed